Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Polidori

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Biogerontology|November 16, 2001
Peripheral non-enzymatic antioxidant changes with human aging: a selective status reportM C Polidori, A Cherubini, U Senin, et al.
Regulatory Peptides|February 1, 1987
Effect of kassinin, neurokinin A and neurokinin B on drinking behaviour in the pigeonM Massi, M Perfumi, C Polidori, et al.
Peptides|January 23, 1998
Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in ratsC Polidori, R Ciccocioppo, G De Caro, et al.
Pharmacological Research Communications|September 1, 1988
Vasopressin release induced by intracranial injection of eledoisin is mediated by central angiotensin IIM Perfumi, A Sajia, G Costa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1994
Protective effect of nicardipine treatment on renal microanatomical changes in spontaneously hypertensive ratsF Ferrante, F Abbate, E Ciriaco, et al.
European Journal of Pharmacology|April 24, 1995
The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in ratsC Polidori, R Ciccocioppo, P Pompei, et al.
Deutsche Medizinische Wochenschrift (1946)|February 10, 2012
[Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease]M C Polidori, W Stahl, S De Spirt, et al.
Biochemical Society Transactions|August 12, 2014
Hypercholesterolaemia-induced oxidative stress at the blood-brain barrierIrundika H K Dias, Maria C Polidori, Helen R Griffiths
Frontiers in Pharmacology|July 9, 2014
Nutraceuticals in cognitive impairment and Alzheimer's diseaseP Mecocci, C Tinarelli, R J Schulz, et al.
European Journal of Pharmacology|August 26, 1998
Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatmentC Polidori, R Ciccocioppo, D Nisato, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Biogerontology|November 16, 2001
Peripheral non-enzymatic antioxidant changes with human aging: a selective status reportM C Polidori, A Cherubini, U Senin, et al.
Regulatory Peptides|February 1, 1987
Effect of kassinin, neurokinin A and neurokinin B on drinking behaviour in the pigeonM Massi, M Perfumi, C Polidori, et al.
Peptides|January 23, 1998
Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in ratsC Polidori, R Ciccocioppo, G De Caro, et al.
Pharmacological Research Communications|September 1, 1988
Vasopressin release induced by intracranial injection of eledoisin is mediated by central angiotensin IIM Perfumi, A Sajia, G Costa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1994
Protective effect of nicardipine treatment on renal microanatomical changes in spontaneously hypertensive ratsF Ferrante, F Abbate, E Ciriaco, et al.
European Journal of Pharmacology|April 24, 1995
The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in ratsC Polidori, R Ciccocioppo, P Pompei, et al.
Deutsche Medizinische Wochenschrift (1946)|February 10, 2012
[Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease]M C Polidori, W Stahl, S De Spirt, et al.
Biochemical Society Transactions|August 12, 2014
Hypercholesterolaemia-induced oxidative stress at the blood-brain barrierIrundika H K Dias, Maria C Polidori, Helen R Griffiths
Frontiers in Pharmacology|July 9, 2014
Nutraceuticals in cognitive impairment and Alzheimer's diseaseP Mecocci, C Tinarelli, R J Schulz, et al.
European Journal of Pharmacology|August 26, 1998
Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatmentC Polidori, R Ciccocioppo, D Nisato, et al.
Pageof 12